Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Lombardi

Interventional Cardiology Seattle, WA Medical Doctor

NPI 1942250717 CMS profile 360859

1959 Ne Pacific St, Seattle, WA 98195

Open in the dashboard

General payments

$901,687

501 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$609,500

4 holdings reported · through program year 2025

Research they led as principal investigator

$102,001 paid to institutions, not to them · program years 2019–2023

Through program year 2025, William Lombardi of Seattle, WA is reported in the CMS Open Payments database as having received $901,687 across 501 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $102,001 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $609,500 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,871 60
2024 General $54,429 28
2023 General $167,041 72
2022 General $133,121 75
2021 General $83,757 24
2020 General $84,935 73
2019 General $367,534 169
2025 Ownership $209,500 2
2024 Ownership $200,000 1
2023 Ownership $200,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Lombardi
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to William Lombardi were reported at $10,871. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year William Lombardi Interventional Cardiology median Middle half National median
2019 $367,534 $1,097 $329–$3,048 $163
2020 $84,935 $473 $161–$1,480 $114
2021 $83,757 $677 $233–$1,827 $132
2022 $133,121 $978 $333–$2,724 $149
2023 $167,041 $1,136 $382–$2,986 $160
2024 $54,429 $1,181 $395–$3,326 $164
2025 $10,871 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Asahi Intecc Co., Ltd. $274,230 17 payments
  2. Corindus Inc. $238,549 15 payments
  3. Asahi Intecc USA, Inc. $149,632 55 payments
  4. Boston Scientific Corporation $94,696 129 payments
  5. Medtronic, Inc. $31,339 35 payments
  6. Reflow Medical Inc $23,484 7 payments
  7. Medtronic Vascular, Inc. $21,862 39 payments
  8. Siemens Medical Solutions USA, Inc. $15,732 35 payments
  9. Abbott Laboratories $14,577 57 payments
  10. Vascular Solutions, Inc. $12,440 5 payments
  11. Other $25,147 107 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $402,359 20 payments
  2. Current or prospective ownership or investment interest $234,609 1 payment
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,575 50 payments
  4. Consulting Fee $49,970 22 payments
  5. Travel and Lodging $45,957 61 payments
  6. Food and Beverage $25,567 337 payments
  7. Honoraria $13,250 8 payments
  8. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,400 2 payments
Products named General payments · program years 2019–2025
  1. ASAHI PTCA Guide Wire ASAHI Gladius Mongo 14 $235,032 8 payments
  2. ASAHI PTCA Guide Wire Cardiovascular $79,232 12 payments
  3. ASAHI Corsair Pro XS Microcatheter $47,234 6 payments
  4. CROSSBOSS $29,870 16 payments
  5. PERIPHERAL VASCULAR $28,758 8 payments
  6. GENERAL VASCULAR ACCESS $21,749 5 payments
  7. RESOLUTE ONYX $19,939 6 payments
  8. ASAHI PTCA Guide Wire Interventional cardiology $18,962 9 payments
  9. Resolute $13,084 19 payments
  10. INTERVENTIONAL PRODUCTS $12,462 6 payments
  11. Other $103,418 316 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$76,870

Medicare's payments for the services billed

Medicare patients

135

Average age 73

Services billed

478

35 women, 100 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 55%
Diabetes 45%
Arthritis 43%
Chronic kidney disease 37%
Atrial fibrillation 36%
Depression 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

501 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record